Sodium Gluconate, Gluconic Acid, and Derivative Products From the People's Republic of China: Preliminary Determination of Sales at Less Than Fair Value, 31949-31951 [2018-14729]
Download as PDF
Federal Register / Vol. 83, No. 132 / Tuesday, July 10, 2018 / Notices
Estimated Total Annual Cost to
Public: $0. (This is not the cost of
respondents’ time, but the indirect costs
respondents may incur for such things
as purchases of specialized software or
hardware needed to report, or
expenditures for accounting or records
maintenance services required
specifically by the collection.)
Respondent Obligation: Voluntary.
Legal Authority: Title 13 U.S.C. 16,
141, and 193.
V. Request for Comments
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden
(including hours and cost) of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology.
Summarization of comments
submitted in response to this notice will
be included in the request for OMB
approval of this information collection.
Comments will also become a matter of
public record.
Sheleen Dumas,
Departmental Lead PRA Officer, Office of the
Chief Information Officer.
[FR Doc. 2018–14695 Filed 7–9–18; 8:45 am]
BILLING CODE 3510–07–P
are invited to comment on this
preliminary determination.
DATES: Applicable July 10, 2018.
FOR FURTHER INFORMATION CONTACT:
Magd Zalok or Stephen Bailey, AD/CVD
Operations, Office IV, Enforcement &
Compliance, International Trade
Administration, Department of
Commerce, 1401 Constitution Avenue
NW, Washington, DC 20230; telephone:
(202) 482–4162 or (202) 482–0193
respectively.
SUPPLEMENTARY INFORMATION:
Background
This preliminary determination is in
accordance with section 733(b) of the
Tariff Act of 1930, as amended (the Act).
Commerce published the notice of
initiation of this investigation on
January 4, 2018.1 On May 1, 2018,
Commerce postponed the preliminary
determination of this investigation.2
Commerce has exercised its discretion
to toll deadlines for the duration of the
closure of the Federal Government from
January 20 through 22, 2018.3 The
revised deadline for the preliminary
determination for this investigation is
now July 2, 2018.
For a complete description of the
events that followed the initiation of
this investigation, see the Preliminary
Decision Memorandum.4 A list of topics
included in the Preliminary Decision
Memorandum is included as Appendix
II to this notice. The Preliminary
Decision Memorandum is a public
document and is on file electronically
via Enforcement and Compliance’s
Antidumping and Countervailing Duty
Centralized Electronic Service System
(ACCESS). ACCESS is available to
registered users at https://
DEPARTMENT OF COMMERCE
International Trade Administration
[A–570–071]
Sodium Gluconate, Gluconic Acid, and
Derivative Products From the People’s
Republic of China: Preliminary
Determination of Sales at Less Than
Fair Value
Enforcement and Compliance,
International Trade Administration,
Department of Commerce.
SUMMARY: The U.S. Department of
Commerce (Commerce) preliminarily
determines that sodium gluconate,
gluconic acid, and derivative products
from the People’s Republic of China
(China) are, or are likely to be, sold in
the United States at less than fair value
(LTFV). The period of investigation
(POI) is April 1, 2017, through
September 30, 2017. Interested parties
amozie on DSK3GDR082PROD with NOTICES1
AGENCY:
VerDate Sep<11>2014
17:27 Jul 09, 2018
Jkt 244001
1 See Sodium Gluconate, Gluconic Acid, and
Derivative Products from France and the People’s
Republic of China: Initiation of Less-Than-FairValue Investigations, 83 FR 516 (January 4, 2018)
(Initiation Notice).
2 See Sodium Gluconate, Gluconic Acid, and
Derivative Products from the People’s Republic of
China: Postponement of Preliminary Determination
in the Less-Than-Fair-Value Investigation, 83 FR
19050 (May 1, 2018).
3 See Memorandum, for The Record from
Christian Marsh, Deputy Assistant Secretary for
Enforcement and Compliance, performing the nonexclusive functions and duties of the Assistant
Secretary for Enforcement and Compliance,
‘‘Deadlines Affected by the Shutdown of the
Federal Government,’’ (Tolling Memorandum),
dated January 23, 2018. All deadlines in this
segment of the proceeding have been extended by
3 days.
4 See Memorandum, ‘‘Decision Memorandum for
the Preliminary Determination of the Less-ThanFair-Value Investigation of Sodium Gluconate,
Gluconic Acid, and Derivative Products from
People’s Republic of China (Preliminary Decision
Memorandum), dated concurrently with, and
hereby adopted by, this notice. See also Appendix
I.
PO 00000
Frm 00003
Fmt 4703
Sfmt 4703
31949
access.trade.gov, and to all parties in the
Central Records Unit, room B8024 of the
main Department of Commerce
building. In addition, a complete
version of the Preliminary Decision
Memorandum can be accessed directly
at https://enforcement.trade.gov/frn/.
The signed and the electronic versions
of the Preliminary Decision
Memorandum are identical in content.
Scope of the Investigation
The products covered by this
investigation are sodium gluconate,
gluconic acid, and derivative products
from China. For a complete description
of the scope of this investigation, see
Appendix I to this notice.
Scope Comments
In accordance with the preamble to
Commerce’s regulations,5 the Initiation
Notice set aside a period of time for
parties to raise issues regarding product
coverage (scope).6 On January 9, 2018,
and January 19, 2018, Commerce
received scope comments and rebuttal
comments, respectively.7 For further
details, see the Preliminary Decision
Memorandum accompanying this
notice. However, Commerce is not
preliminarily modifying the scope
language as it appeared in the Initiation
Notice. See the scope in Appendix I to
this notice.
Methodology
Commerce is conducting this
investigation in accordance with section
731 of the Act. Pursuant to sections
776(a) and (b) of the Act, Commerce
preliminarily has relied upon facts
otherwise available, with adverse
inferences, for the China-wide entity.
The China-wide entity includes
mandatory respondents Shandong
Fuyang Biotechnology Co., Ltd./
Shandong Fuyang Biology Starch Co.,
Ltd. (Shandong Fuyang) 8 Qingdao
5 See Antidumping Duties; Countervailing Duties,
62 FR 27296, 27323 (May 19, 1997).
6 See Initiation Notice.
7 See Letter from Jungbunzlauer S.A. to
Commerce, ‘‘Investigations Sodium Gluconate,
Gluconic Acid, and Derivative Products from
France and China—Junsbunzlauers Comments
regarding Scope,’’ dated January 9, 2018, and PMP’s
Letter to Commerce, ‘‘Countervailing and
Antidumping Duty Investigation of Sodium
Gluconate, Gluconic Acid and Derivative Products
from the People’s Republic of China: Petitioner’s
Rebuttal Comments on Scope Comments,’’ dated
January 19, 2018.
8 See Memorandum, ‘‘Less-Than-Fair-Value
Investigation of Sodium Gluconate, Gluconic Acid,
and Derivative Products from the People’s Republic
of China: Respondent Selection,’’ dated January 17,
2018 (Initial Respondent Selection Memorandum).
See also Shandong Fuyang letter, ‘‘Notice of NonParticipation in Investigation,’’ dated March 30,
2018.
E:\FR\FM\10JYN1.SGM
10JYN1
31950
Federal Register / Vol. 83, No. 132 / Tuesday, July 10, 2018 / Notices
Dongxiao Enterprise Co., Ltd. (Qingdao
Dongxiao),9 Zhejiang Tianyi Food
Additives Co., Ltd. (Tianyi Food) 10 and
Dezhou Huiyang Biotechnology Co.,
Ltd. (Dezhou Huiyang).11 These
companies failed to respond to
Commerce’s requests for information
and withdrew from participation in this
investigation. For a full description of
the methodology underlying
Commerce’s preliminary determination,
see the Preliminary Decision
Memorandum.
Separate Rate
In proceedings involving NME
countries, Commerce maintains a
rebuttable presumption that all
companies within the country are
subject to government control and,
therefore, should be assessed a single
weighted-average dumping margin.12
Commerce’s policy is to assign all
exporters of subject merchandise that
are in an NME country this single rate
unless an exporter can demonstrate that
it is sufficiently independent so as to be
entitled to a separate rate.13 Commerce
preliminarily finds that the evidence
placed on the record of this
investigation by Anhui Xingzhou
Medicine Food Co., Ltd. (Xingzhou
Medicine) 14 demonstrates an absence of
de jure and de facto government control.
Commerce assigned Xingzhou Medicine
a separate rate, which is the petition
rate, because it is the only rate available
on the record of this proceeding. For a
full description of the methodology
underlying Commerce’s preliminary
determination, see the Preliminary
Decision Memorandum.
Combination Rates
In the Initiation Notice,15 Commerce
stated that it would calculate producer/
exporter combination rates for the
respondents that are eligible for a
separate rate in this investigation. Policy
Bulletin 05.1 describes this practice.16
Because Commerce preliminarily
determined that these mandatory
respondents should be considered part
of the China-wide entity, and assigned,
as adverse facts available, the petition
rate to the China-wide entity, Commerce
did not calculate producer/exporter
combination rates for those companies.
Preliminary Determination
Commerce preliminarily determines
that the following estimated weightedaverage dumping margins exist:
Estimated
weightedaverage
dumping
margin
(percent)
Exporter
Producer
Anhui Xingzhou Medicine Food Co., Ltd ....................................
Anhui Xingzhou Medicine Food Co., Ltd ....................................
Xiwang Pharmaceutical Co., Ltd ...............................................
Zhucheng Shuguang Biotech Co., Ltd ......................................
China-wide Entity 17
213.15
213.15
213.15
In accordance with section 733(d)(2)
of the Act, Commerce will direct U.S.
Customs and Border Protection (CBP) to
suspend liquidation of subject
merchandise as described in the scope
of the investigation section entered, or
withdrawn from warehouse, for
consumption on or after the date of
publication of this notice in the Federal
Register, as discussed below. Further,
pursuant to section 733(d)(1)(B) of the
Act and 19 CFR 351.205(d), Commerce
will instruct CBP to require a cash
deposit equal to the weighted average
amount by which normal value exceeds
U.S. price, as indicated in the chart
above as follows: (1) For the producer/
exporter combinations listed in the table
above, the cash deposit rate is equal to
the estimated weighted-average
dumping margin listed for that
combination in the table; (2) for all
combinations of China producers/
exporters of merchandise under
consideration that have not established
eligibility for their own separate rates,
the cash deposit rate will be equal to the
estimated weighted-average dumping
margin established for the China-wide
entity; and (3) for all third-country
exporters of merchandise under
consideration not listed in the table
above, the cash deposit rate is the cash
deposit rate applicable to the China
producer/exporter combination (or the
China-wide entity) that supplied that
third-country exporter.
As described in the Preliminary
Decision Memorandum, in this
preliminary determination, no
adjustments pursuant to sections
777A(f) and 772(c)(1)(C) of the Act are
being made for cash deposit purposes.
These suspension of liquidation
instructions will remain in effect until
further notice.
9 See Qingdao Dongxiao, see the Initial
Respondent Selection Memorandum and Qingdao
Dongxiao’s Letter, ‘‘Withdrawal from
Participation,’’ dated February 14, 2018.
10 See Tianyi Food, see Commerce’s
Memorandum, ‘‘Selection of Additional
Respondent,’’ dated March 5, 2018 and Tianyi
Food’s Letter, ‘‘Withdrawal from Participation,’’
dated March 8, 2018.
11 See Dezhou Huiyang’s Commerce’s
Memorandum, ‘‘Selection of Additional
Respondent,’’ dated March 9, 2018 and Dezhou
Huiyang’s Letter, ‘‘Dezhou Huiyang Biotechnology
Co., Ltd. Withdrawal of Participation in
Antidumping Duty Investigation,’’ dated March 13,
2018.
12 See, e.g., Polyethylene Terephthalate Film,
Sheet, and Strip from the People’s Republic of
China: Final Determination of Sales at Less Than
Fair Value, 73 FR 55039, 55040 (September 24,
2008).
13 See Final Determination of Sales at Less Than
Fair Value: Sparklers from the People’s Republic of
China, 56 FR 20588, 20589 (May 6, 1991)
(Sparklers).
14 See, e.g., Xingzhou Medicine’s Letter,
‘‘Xingzhou Medicine Separate Rate Application,’’
dated February 5, 2018; Commerce’s Letter, ‘‘1st
Supplemental Questionnaire Regarding the
Separate Rate Application for Anhui Xingzhou
Medicine Food Co., Ltd.,’’ dated February 27, 2018;
Xingzhou Medicine’s Letter, ‘‘Supplemental SRA
Questionnaire Response,’’ dated March 6, 2018;
Commerce’s Letter, ‘‘2nd Supplemental
Questionnaire regarding the Separate Rate
Application for Anhui Xingzhou Medicine Food
Co., Ltd.,’’ dated March 22, 2018. and Xingzhou
Medicine’s Letter, ‘‘Second Supplemental SRA
Questionnaire Response,’’ dated March 29, 2018.
15 See Initiation Notice at 42652–53.
16 See Enforcement and Compliance’s Policy
Bulletin No. 05.1, regarding, ‘‘Separate-Rates
Practice and Application of Combination Rates in
Antidumping Investigations involving Non-Market
Economy Countries,’’ (April 5, 2005) (Policy
Bulletin 05.1), available on Commerce’s website at
https://enforcement.trade.gov/policy/bull05-1.pdf.
17 The China-wide Entity includes Dezhou
Huiyang, Qingdao Dongxiao, Shandong Fuyang,
and Tianyi Food.
amozie on DSK3GDR082PROD with NOTICES1
Suspension of Liquidation
VerDate Sep<11>2014
17:27 Jul 09, 2018
Jkt 244001
PO 00000
Frm 00004
Fmt 4703
Sfmt 4703
Disclosure
Normally, Commerce discloses to
interested parties the calculations
performed in connection with a
preliminary determination within five
days of its public announcement or, if
there is no public announcement,
within five days of the date of
publication of this notice in accordance
with 19 CFR 351.224(b). However,
E:\FR\FM\10JYN1.SGM
10JYN1
Federal Register / Vol. 83, No. 132 / Tuesday, July 10, 2018 / Notices
because Commerce preliminarily
determined that the mandatory
respondents should be considered to be
part of the China-wide entity, and
assigned the China-wide entity an AFA
rate based solely on the petition, there
are no calculations to disclose.
Verification
Because the mandatory respondents
in this investigation did not provide
information requested by Commerce
and Commerce preliminarily determines
in accordance with section 776(b) of the
Act that each of the mandatory
respondents to have been
uncooperative, verification will not be
conducted.
amozie on DSK3GDR082PROD with NOTICES1
Public Comment
Case briefs or other written comments
may be submitted to the Assistant
Secretary for Enforcement and
Compliance no later than 30 days after
the date of publication of the
preliminary determination, unless the
Secretary alters the time limit. Rebuttal
briefs, limited to issues raised in case
briefs, may be submitted no later than
five days after the deadline date for case
briefs.18 Pursuant to 19 CFR
351.309(c)(2) and (d)(2), parties who
submit case briefs or rebuttal briefs in
this investigation are encouraged to
submit with each argument: (1) A
statement of the issue; (2) a brief
summary of the argument; and (3) a
table of authorities.
Pursuant to 19 CFR 351.310(c),
interested parties who wish to request a
hearing, limited to issues raised in the
case and rebuttal briefs, must submit a
written request to the Assistant
Secretary for Enforcement and
Compliance, U.S. Department of
Commerce, within 30 days after the date
of publication of this notice. Requests
should contain the party’s name,
address, and telephone number, the
number of participants, whether any
participant is a foreign national, and a
list of the issues to be discussed. If a
request for a hearing is made, Commerce
intends to hold the hearing at the U.S.
Department of Commerce, 1401
Constitution Avenue NW, Washington,
DC 20230, at a time and date to be
determined. Parties should confirm by
telephone the date, time, and location of
the hearing two days before the
scheduled date.
Final Determination
Section 735(a)(1) of the Act and 19
CFR 351.210(b)(1) provide that
Commerce will issue the final
18 See 19 CFR 351.309; see also 19 CFR 351.303
(for general filing requirements).
VerDate Sep<11>2014
17:27 Jul 09, 2018
Jkt 244001
determination within 75 days after the
date of its preliminary determination.
Accordingly, Commerce will make its
final determination no later than 75
days after the signature date of this
preliminary determination.
International Trade Commission
Notification
In accordance with section 733(f) of
the Act, Commerce will notify the
International Trade Commission (ITC) of
its preliminary determination of sales at
LTFV. If the final determination is
affirmative, the ITC will determine
before the later of 120 days after the date
of this preliminary determination or 45
days after the final determination
whether imports of the subject
merchandise are materially injuring, or
threaten material injury to, the U.S.
industry.
Notification to Interested Parties
This determination is issued and
published in accordance with sections
733(f) and 777(i)(1) of the Act and 19
CFR 351.205(c).
Dated: July 2, 2018.
Gary Taverman,
Deputy Assistant Secretary for Antidumping
and Countervailing Duty Operations
performing the non-exclusive functions and
duties of the Assistant Secretary for
Enforcement and Compliance.
31951
The merchandise covered by the scope of
the investigation is currently classified in the
Harmonized Tariff Schedule of the United
States (HTSUS) under subheadings
2918.16.1000, 2918.16.5010, and
2932.20.5020. Merchandise covered by the
scope may also enter under HTSUS
subheadings 2918.16.5050, 3824.99.2890,
and 3824.99.9295. Although the HTSUS
subheadings and CAS registry numbers are
provided for convenience and customs
purposes, the written description of the
merchandise is dispositive.
Appendix II
List of Topics Discussed in the Preliminary
Decision Memorandum
I. Summary
II. Background
III. Period of Investigation
IV. Scope Comments
V. Scope of the Investigation
VI. Discussion of the Methodology
A. Non-Market Economy Country
B. Surrogate Country and Surrogate Value
Comments
C. Separate Rates
D. China-Wide Entity
E. Use of Facts Otherwise Available With
an Adverse Inference
VII. Adjustment Under Section 777(A)(f) of
the Act
VIII. Adjustments to Cash Deposit Rates for
Export Subsidies
IX. Verification
X. Conclusion
[FR Doc. 2018–14729 Filed 7–9–18; 8:45 am]
BILLING CODE 3510–DS–P
Appendix I
Scope of the Investigation
The scope of the investigation covers all
grades of sodium gluconate, gluconic acid,
liquid gluconate, and glucono delta lactone
(GDL) (collectively GNA Products),
regardless of physical form (including, but
not limited to substrates; solutions; dry
granular form or powders, regardless of
particle size; or as a slurry). The scope also
includes GNA Products that have been
blended or are in solution with other
product(s) where the resulting mix contains
35 percent or more of sodium gluconate,
gluconic acid, liquid gluconate, and/or GDL
by dry weight.
Sodium gluconate has a molecular formula
of NaC6H11O7. Sodium gluconate has a
Chemical Abstract Service (CAS) registry
number of 527–07–1, and can also be called
‘‘sodium salt of gluconic acid’’ and/or
sodium 2, 3, 4, 5, 6 pentahydroxyhexanoate.
Gluconic acid has a molecular formula of
C6H12O7. Gluconic acid has a CAS registry
number of 526–95–4, and can also be called
2, 3, 4, 5, 6 pentahydroxycaproic acid. Liquid
gluconate is a blend consisting only of
gluconic acid and sodium gluconate in an
aqueous solution. Liquid gluconate has CAS
registry numbers of 527–07–1, 526–95–4, and
7732–18–5, and can also be called 2, 3, 4, 5,
6-pentahydroxycaproic acid-hexanoate. GDL
has a molecular formula of C6H10O6. GDL has
a CAS registry number of 90–80–2, and can
also be called d-glucono-1,5-lactone.
PO 00000
Frm 00005
Fmt 4703
Sfmt 4703
DEPARTMENT OF COMMERCE
International Trade Administration
[C–570–978]
High Pressure Steel Cylinders From
the People’s Republic of China:
Preliminary Results of Countervailing
Duty Administrative Review; 2016
Enforcement and Compliance,
International Trade Administration,
Department of Commerce.
SUMMARY: The Department of Commerce
(Commerce) is conducting an
administrative review of the
countervailing duty (CVD) order on high
pressure steel cylinders (steel cylinders)
from the People’s Republic of China
(PRC) for the period of review January
1, 2016, through December 31, 2016.
Interested parties are invited to
comment on these preliminary results.
DATES: Applicable July 10, 2018.
FOR FURTHER INFORMATION CONTACT:
Toby Vandall or Aimee Phelan, AD/
CVD Operations, Office I, Enforcement
and Compliance, International Trade
Administration, U.S. Department of
Commerce, 1401 Constitution Avenue
NW, Washington, DC 20230; telephone:
AGENCY:
E:\FR\FM\10JYN1.SGM
10JYN1
Agencies
[Federal Register Volume 83, Number 132 (Tuesday, July 10, 2018)]
[Notices]
[Pages 31949-31951]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-14729]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
International Trade Administration
[A-570-071]
Sodium Gluconate, Gluconic Acid, and Derivative Products From the
People's Republic of China: Preliminary Determination of Sales at Less
Than Fair Value
AGENCY: Enforcement and Compliance, International Trade Administration,
Department of Commerce.
SUMMARY: The U.S. Department of Commerce (Commerce) preliminarily
determines that sodium gluconate, gluconic acid, and derivative
products from the People's Republic of China (China) are, or are likely
to be, sold in the United States at less than fair value (LTFV). The
period of investigation (POI) is April 1, 2017, through September 30,
2017. Interested parties are invited to comment on this preliminary
determination.
DATES: Applicable July 10, 2018.
FOR FURTHER INFORMATION CONTACT: Magd Zalok or Stephen Bailey, AD/CVD
Operations, Office IV, Enforcement & Compliance, International Trade
Administration, Department of Commerce, 1401 Constitution Avenue NW,
Washington, DC 20230; telephone: (202) 482-4162 or (202) 482-0193
respectively.
SUPPLEMENTARY INFORMATION:
Background
This preliminary determination is in accordance with section 733(b)
of the Tariff Act of 1930, as amended (the Act). Commerce published the
notice of initiation of this investigation on January 4, 2018.\1\ On
May 1, 2018, Commerce postponed the preliminary determination of this
investigation.\2\ Commerce has exercised its discretion to toll
deadlines for the duration of the closure of the Federal Government
from January 20 through 22, 2018.\3\ The revised deadline for the
preliminary determination for this investigation is now July 2, 2018.
---------------------------------------------------------------------------
\1\ See Sodium Gluconate, Gluconic Acid, and Derivative Products
from France and the People's Republic of China: Initiation of Less-
Than-Fair-Value Investigations, 83 FR 516 (January 4, 2018)
(Initiation Notice).
\2\ See Sodium Gluconate, Gluconic Acid, and Derivative Products
from the People's Republic of China: Postponement of Preliminary
Determination in the Less-Than-Fair-Value Investigation, 83 FR 19050
(May 1, 2018).
\3\ See Memorandum, for The Record from Christian Marsh, Deputy
Assistant Secretary for Enforcement and Compliance, performing the
non-exclusive functions and duties of the Assistant Secretary for
Enforcement and Compliance, ``Deadlines Affected by the Shutdown of
the Federal Government,'' (Tolling Memorandum), dated January 23,
2018. All deadlines in this segment of the proceeding have been
extended by 3 days.
---------------------------------------------------------------------------
For a complete description of the events that followed the
initiation of this investigation, see the Preliminary Decision
Memorandum.\4\ A list of topics included in the Preliminary Decision
Memorandum is included as Appendix II to this notice. The Preliminary
Decision Memorandum is a public document and is on file electronically
via Enforcement and Compliance's Antidumping and Countervailing Duty
Centralized Electronic Service System (ACCESS). ACCESS is available to
registered users at https://access.trade.gov, and to all parties in the
Central Records Unit, room B8024 of the main Department of Commerce
building. In addition, a complete version of the Preliminary Decision
Memorandum can be accessed directly at https://enforcement.trade.gov/frn/. The signed and the electronic versions of the Preliminary
Decision Memorandum are identical in content.
---------------------------------------------------------------------------
\4\ See Memorandum, ``Decision Memorandum for the Preliminary
Determination of the Less-Than-Fair-Value Investigation of Sodium
Gluconate, Gluconic Acid, and Derivative Products from People's
Republic of China (Preliminary Decision Memorandum), dated
concurrently with, and hereby adopted by, this notice. See also
Appendix I.
---------------------------------------------------------------------------
Scope of the Investigation
The products covered by this investigation are sodium gluconate,
gluconic acid, and derivative products from China. For a complete
description of the scope of this investigation, see Appendix I to this
notice.
Scope Comments
In accordance with the preamble to Commerce's regulations,\5\ the
Initiation Notice set aside a period of time for parties to raise
issues regarding product coverage (scope).\6\ On January 9, 2018, and
January 19, 2018, Commerce received scope comments and rebuttal
comments, respectively.\7\ For further details, see the Preliminary
Decision Memorandum accompanying this notice. However, Commerce is not
preliminarily modifying the scope language as it appeared in the
Initiation Notice. See the scope in Appendix I to this notice.
---------------------------------------------------------------------------
\5\ See Antidumping Duties; Countervailing Duties, 62 FR 27296,
27323 (May 19, 1997).
\6\ See Initiation Notice.
\7\ See Letter from Jungbunzlauer S.A. to Commerce,
``Investigations Sodium Gluconate, Gluconic Acid, and Derivative
Products from France and China--Junsbunzlauers Comments regarding
Scope,'' dated January 9, 2018, and PMP's Letter to Commerce,
``Countervailing and Antidumping Duty Investigation of Sodium
Gluconate, Gluconic Acid and Derivative Products from the People's
Republic of China: Petitioner's Rebuttal Comments on Scope
Comments,'' dated January 19, 2018.
---------------------------------------------------------------------------
Methodology
Commerce is conducting this investigation in accordance with
section 731 of the Act. Pursuant to sections 776(a) and (b) of the Act,
Commerce preliminarily has relied upon facts otherwise available, with
adverse inferences, for the China-wide entity. The China-wide entity
includes mandatory respondents Shandong Fuyang Biotechnology Co., Ltd./
Shandong Fuyang Biology Starch Co., Ltd. (Shandong Fuyang) \8\ Qingdao
[[Page 31950]]
Dongxiao Enterprise Co., Ltd. (Qingdao Dongxiao),\9\ Zhejiang Tianyi
Food Additives Co., Ltd. (Tianyi Food) \10\ and Dezhou Huiyang
Biotechnology Co., Ltd. (Dezhou Huiyang).\11\ These companies failed to
respond to Commerce's requests for information and withdrew from
participation in this investigation. For a full description of the
methodology underlying Commerce's preliminary determination, see the
Preliminary Decision Memorandum.
---------------------------------------------------------------------------
\8\ See Memorandum, ``Less-Than-Fair-Value Investigation of
Sodium Gluconate, Gluconic Acid, and Derivative Products from the
People's Republic of China: Respondent Selection,'' dated January
17, 2018 (Initial Respondent Selection Memorandum). See also
Shandong Fuyang letter, ``Notice of Non-Participation in
Investigation,'' dated March 30, 2018.
\9\ See Qingdao Dongxiao, see the Initial Respondent Selection
Memorandum and Qingdao Dongxiao's Letter, ``Withdrawal from
Participation,'' dated February 14, 2018.
\10\ See Tianyi Food, see Commerce's Memorandum, ``Selection of
Additional Respondent,'' dated March 5, 2018 and Tianyi Food's
Letter, ``Withdrawal from Participation,'' dated March 8, 2018.
\11\ See Dezhou Huiyang's Commerce's Memorandum, ``Selection of
Additional Respondent,'' dated March 9, 2018 and Dezhou Huiyang's
Letter, ``Dezhou Huiyang Biotechnology Co., Ltd. Withdrawal of
Participation in Antidumping Duty Investigation,'' dated March 13,
2018.
---------------------------------------------------------------------------
Separate Rate
In proceedings involving NME countries, Commerce maintains a
rebuttable presumption that all companies within the country are
subject to government control and, therefore, should be assessed a
single weighted-average dumping margin.\12\ Commerce's policy is to
assign all exporters of subject merchandise that are in an NME country
this single rate unless an exporter can demonstrate that it is
sufficiently independent so as to be entitled to a separate rate.\13\
Commerce preliminarily finds that the evidence placed on the record of
this investigation by Anhui Xingzhou Medicine Food Co., Ltd. (Xingzhou
Medicine) \14\ demonstrates an absence of de jure and de facto
government control. Commerce assigned Xingzhou Medicine a separate
rate, which is the petition rate, because it is the only rate available
on the record of this proceeding. For a full description of the
methodology underlying Commerce's preliminary determination, see the
Preliminary Decision Memorandum.
---------------------------------------------------------------------------
\12\ See, e.g., Polyethylene Terephthalate Film, Sheet, and
Strip from the People's Republic of China: Final Determination of
Sales at Less Than Fair Value, 73 FR 55039, 55040 (September 24,
2008).
\13\ See Final Determination of Sales at Less Than Fair Value:
Sparklers from the People's Republic of China, 56 FR 20588, 20589
(May 6, 1991) (Sparklers).
\14\ See, e.g., Xingzhou Medicine's Letter, ``Xingzhou Medicine
Separate Rate Application,'' dated February 5, 2018; Commerce's
Letter, ``1st Supplemental Questionnaire Regarding the Separate Rate
Application for Anhui Xingzhou Medicine Food Co., Ltd.,'' dated
February 27, 2018; Xingzhou Medicine's Letter, ``Supplemental SRA
Questionnaire Response,'' dated March 6, 2018; Commerce's Letter,
``2nd Supplemental Questionnaire regarding the Separate Rate
Application for Anhui Xingzhou Medicine Food Co., Ltd.,'' dated
March 22, 2018. and Xingzhou Medicine's Letter, ``Second
Supplemental SRA Questionnaire Response,'' dated March 29, 2018.
---------------------------------------------------------------------------
Combination Rates
In the Initiation Notice,\15\ Commerce stated that it would
calculate producer/exporter combination rates for the respondents that
are eligible for a separate rate in this investigation. Policy Bulletin
05.1 describes this practice.\16\ Because Commerce preliminarily
determined that these mandatory respondents should be considered part
of the China-wide entity, and assigned, as adverse facts available, the
petition rate to the China-wide entity, Commerce did not calculate
producer/exporter combination rates for those companies.
---------------------------------------------------------------------------
\15\ See Initiation Notice at 42652-53.
\16\ See Enforcement and Compliance's Policy Bulletin No. 05.1,
regarding, ``Separate-Rates Practice and Application of Combination
Rates in Antidumping Investigations involving Non-Market Economy
Countries,'' (April 5, 2005) (Policy Bulletin 05.1), available on
Commerce's website at https://enforcement.trade.gov/policy/bull05-1.pdf.
\17\ The China-wide Entity includes Dezhou Huiyang, Qingdao
Dongxiao, Shandong Fuyang, and Tianyi Food.
---------------------------------------------------------------------------
Preliminary Determination
Commerce preliminarily determines that the following estimated
weighted-average dumping margins exist:
------------------------------------------------------------------------
Estimated
weighted-
Exporter Producer average
dumping margin
(percent)
------------------------------------------------------------------------
Anhui Xingzhou Medicine Food Xiwang Pharmaceutical 213.15
Co., Ltd. Co., Ltd.
Anhui Xingzhou Medicine Food Zhucheng Shuguang 213.15
Co., Ltd. Biotech Co., Ltd.
rrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrr
China-wide Entity \17\ 213.15
------------------------------------------------------------------------
Suspension of Liquidation
In accordance with section 733(d)(2) of the Act, Commerce will
direct U.S. Customs and Border Protection (CBP) to suspend liquidation
of subject merchandise as described in the scope of the investigation
section entered, or withdrawn from warehouse, for consumption on or
after the date of publication of this notice in the Federal Register,
as discussed below. Further, pursuant to section 733(d)(1)(B) of the
Act and 19 CFR 351.205(d), Commerce will instruct CBP to require a cash
deposit equal to the weighted average amount by which normal value
exceeds U.S. price, as indicated in the chart above as follows: (1) For
the producer/exporter combinations listed in the table above, the cash
deposit rate is equal to the estimated weighted-average dumping margin
listed for that combination in the table; (2) for all combinations of
China producers/exporters of merchandise under consideration that have
not established eligibility for their own separate rates, the cash
deposit rate will be equal to the estimated weighted-average dumping
margin established for the China-wide entity; and (3) for all third-
country exporters of merchandise under consideration not listed in the
table above, the cash deposit rate is the cash deposit rate applicable
to the China producer/exporter combination (or the China-wide entity)
that supplied that third-country exporter.
As described in the Preliminary Decision Memorandum, in this
preliminary determination, no adjustments pursuant to sections 777A(f)
and 772(c)(1)(C) of the Act are being made for cash deposit purposes.
These suspension of liquidation instructions will remain in effect
until further notice.
Disclosure
Normally, Commerce discloses to interested parties the calculations
performed in connection with a preliminary determination within five
days of its public announcement or, if there is no public announcement,
within five days of the date of publication of this notice in
accordance with 19 CFR 351.224(b). However,
[[Page 31951]]
because Commerce preliminarily determined that the mandatory
respondents should be considered to be part of the China-wide entity,
and assigned the China-wide entity an AFA rate based solely on the
petition, there are no calculations to disclose.
Verification
Because the mandatory respondents in this investigation did not
provide information requested by Commerce and Commerce preliminarily
determines in accordance with section 776(b) of the Act that each of
the mandatory respondents to have been uncooperative, verification will
not be conducted.
Public Comment
Case briefs or other written comments may be submitted to the
Assistant Secretary for Enforcement and Compliance no later than 30
days after the date of publication of the preliminary determination,
unless the Secretary alters the time limit. Rebuttal briefs, limited to
issues raised in case briefs, may be submitted no later than five days
after the deadline date for case briefs.\18\ Pursuant to 19 CFR
351.309(c)(2) and (d)(2), parties who submit case briefs or rebuttal
briefs in this investigation are encouraged to submit with each
argument: (1) A statement of the issue; (2) a brief summary of the
argument; and (3) a table of authorities.
---------------------------------------------------------------------------
\18\ See 19 CFR 351.309; see also 19 CFR 351.303 (for general
filing requirements).
---------------------------------------------------------------------------
Pursuant to 19 CFR 351.310(c), interested parties who wish to
request a hearing, limited to issues raised in the case and rebuttal
briefs, must submit a written request to the Assistant Secretary for
Enforcement and Compliance, U.S. Department of Commerce, within 30 days
after the date of publication of this notice. Requests should contain
the party's name, address, and telephone number, the number of
participants, whether any participant is a foreign national, and a list
of the issues to be discussed. If a request for a hearing is made,
Commerce intends to hold the hearing at the U.S. Department of
Commerce, 1401 Constitution Avenue NW, Washington, DC 20230, at a time
and date to be determined. Parties should confirm by telephone the
date, time, and location of the hearing two days before the scheduled
date.
Final Determination
Section 735(a)(1) of the Act and 19 CFR 351.210(b)(1) provide that
Commerce will issue the final determination within 75 days after the
date of its preliminary determination. Accordingly, Commerce will make
its final determination no later than 75 days after the signature date
of this preliminary determination.
International Trade Commission Notification
In accordance with section 733(f) of the Act, Commerce will notify
the International Trade Commission (ITC) of its preliminary
determination of sales at LTFV. If the final determination is
affirmative, the ITC will determine before the later of 120 days after
the date of this preliminary determination or 45 days after the final
determination whether imports of the subject merchandise are materially
injuring, or threaten material injury to, the U.S. industry.
Notification to Interested Parties
This determination is issued and published in accordance with
sections 733(f) and 777(i)(1) of the Act and 19 CFR 351.205(c).
Dated: July 2, 2018.
Gary Taverman,
Deputy Assistant Secretary for Antidumping and Countervailing Duty
Operations performing the non-exclusive functions and duties of the
Assistant Secretary for Enforcement and Compliance.
Appendix I
Scope of the Investigation
The scope of the investigation covers all grades of sodium
gluconate, gluconic acid, liquid gluconate, and glucono delta
lactone (GDL) (collectively GNA Products), regardless of physical
form (including, but not limited to substrates; solutions; dry
granular form or powders, regardless of particle size; or as a
slurry). The scope also includes GNA Products that have been blended
or are in solution with other product(s) where the resulting mix
contains 35 percent or more of sodium gluconate, gluconic acid,
liquid gluconate, and/or GDL by dry weight.
Sodium gluconate has a molecular formula of
NaC6H11O7. Sodium gluconate has a
Chemical Abstract Service (CAS) registry number of 527-07-1, and can
also be called ``sodium salt of gluconic acid'' and/or sodium 2, 3,
4, 5, 6 pentahydroxyhexanoate. Gluconic acid has a molecular formula
of C6H12O7. Gluconic acid has a CAS
registry number of 526-95-4, and can also be called 2, 3, 4, 5, 6
pentahydroxycaproic acid. Liquid gluconate is a blend consisting
only of gluconic acid and sodium gluconate in an aqueous solution.
Liquid gluconate has CAS registry numbers of 527-07-1, 526-95-4, and
7732-18-5, and can also be called 2, 3, 4, 5, 6-pentahydroxycaproic
acid-hexanoate. GDL has a molecular formula of
C6H10O6. GDL has a CAS registry
number of 90-80-2, and can also be called d-glucono-1,5-lactone.
The merchandise covered by the scope of the investigation is
currently classified in the Harmonized Tariff Schedule of the United
States (HTSUS) under subheadings 2918.16.1000, 2918.16.5010, and
2932.20.5020. Merchandise covered by the scope may also enter under
HTSUS subheadings 2918.16.5050, 3824.99.2890, and 3824.99.9295.
Although the HTSUS subheadings and CAS registry numbers are provided
for convenience and customs purposes, the written description of the
merchandise is dispositive.
Appendix II
List of Topics Discussed in the Preliminary Decision Memorandum
I. Summary
II. Background
III. Period of Investigation
IV. Scope Comments
V. Scope of the Investigation
VI. Discussion of the Methodology
A. Non-Market Economy Country
B. Surrogate Country and Surrogate Value Comments
C. Separate Rates
D. China-Wide Entity
E. Use of Facts Otherwise Available With an Adverse Inference
VII. Adjustment Under Section 777(A)(f) of the Act
VIII. Adjustments to Cash Deposit Rates for Export Subsidies
IX. Verification
X. Conclusion
[FR Doc. 2018-14729 Filed 7-9-18; 8:45 am]
BILLING CODE 3510-DS-P